Clinical Trial Update: Efficacy and Safety Study of Recombinant Human Arginase 1 in Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on the efficacy and safety of recombinant human arginase 1 in relapsed or refractory acute myeloid leukemia; current trial status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Recombinant Human Arginase 1 (recombinant human arginase 1)

Snippet

Sponsor: Bio-Cancer Treatment International Limited | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: UNKNOWN